PMVP FY 2024 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$88M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$85M

Net Income

-$59M

EPS (Diluted)

$-1.14

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$52M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$191M

Total Liabilities

$15M

Stockholders' Equity

$176M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$1M	+9.0%
Operating Income	-$85M	-$80M	-6.6%
Net Income	-$59M	-$69M	+14.9%